Alan F. Wahl

Development of potent monoclonal antibody auristatin conjugates for cancer therapy

Svetlana O. Doronina, Brian E. Toki, Michael Torgov et al. · Nature Biotechnology · 2003 · 1.2K citations

Cancer Therapy, Polymer-drug Conjugate, Medicine +8

cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity

Joseph A. Francisco, Charles G. Cerveny, Damon L. Meyer et al. · Blood · 2003 · 907 citations

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

Alan F. Wahl, Karen Donaldson, Craig Faircnild et al. · Nature Medicine · 1996 · 661 citations

Signal Transduction, Oncogenic Agent, G2/m Arrest +9

Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery:  Effects of Linker Technology on Efficacy and Toxicity

Svetlana O. Doronina, Brian A. Mendelsohn, Tim D. Bovee et al. · Bioconjugate Chemistry · 2005 · 506 citations

Mab Degradation, Immunology, Immunotherapy +19

Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.

Andrew McShea, Peggy L.R. Harris, Kevin R. Webster et al. · PubMed · 1997 · 431 citations